Innovative Product
Nigento Patch Research Project
Nigento Patch Research Project:
Nigento Patch is innovative product of Gencyst. Team of experts invented a unique bandage containing drug (active antifungal) loaded fine microneedles for the treatment of nail fungal infection. At Gencyst we are offering surgery free treatment for to help one billion people around the globe, who are suffering from this infection. Currently our product is at technology development stage for targeted drug delivery of active antifungal agent to treat fungal infected nails commonly called toe infection.
What is Nail fungus infection:
It Is a fungal infection of the nails that causes discoloration, thickening, and separation from the nail bed. In European countries onychomycosis was found to be the most frequent fungal foot infection and estimates its prevalence at 27%. Prevalence was observed to increase with age. Onychomycosis affects approximately one-third of diabetics and is 56% more frequent in people suffering from psoriasis.
Global prevalence of nail fungal infection:
The fungal infection of the nails causes discoloration, thickening, and separation from the nail bed. In European countries onychomycosis was found to be the most frequent fungal foot infection and estimates its prevalence at 27%. Prevalence was observed to increase with age. Onychomycosis affects approximately one-third of diabetics and is 56% more frequent in people suffering from psoriasis.
Nigento patch is offering compelling solution:
Our experts at Gencyst invented effective and innovative method to deliver the drug to infected finer only through our state-of-the-art devise named Nigento Patch. It is simple like a bandage and easy to apply home devise. It has two unique features. The newly discovered natural anti-fungal agent (discovery of our team, patent pending) and painless penetration of drug loaded micro-needles through hard surface of nail. These micro-needles are designed to be dissolved once penetrated and deliver the drug at right place where the fungus is growing.
Nigento Patch in Globel Market:
Our market survey report revealed that Nigento Patch is satisfying the need of market by providing unique solution towards nail fungal infection. Satisfaction rate of Nigento Patch is up to 95% because it is offering surgery free treatment in just three months and delivery of drug through painless penetration of drug loaded microneedles.
Road Map of Nigento Research Project:
We divided our road map in three phases
Phase-I: Technology development and patent application (Jan 2023 – June 2024).
Phase-II: Clinical trials and regulatory and affair matters (June 2024 – June 2027).
Phase-III: Scale up the marketing model in the world (June 2027 – June 2029).
Team Plan for Nigento Patch Research Project:
Gencyst has great team to achieve the target. Dr Nadeem Hafeez a leading scientist in this team. He is handling technology development, clinical trials, and other related things. Next Wajid, He is expert in regulatory matters and Then Saima, she is software engineer, expert in sales and marketing especially e-marketing.
